Two patients presenting with recurrent multiple cranial neuropathy showed diffuse thickening and gadolinium enhancement of the dura mater on brain MRI. Both had anti-HTLV-I antibodies in serum. A quantitative polymerase chain reaction study ofthe peripheral blood disclosed that the HTLV-I proviral DNA loads increased considerably in one case and moderately in the other. Both showed a spontaneous proliferation of peripheral blood lymphocytes as well as an increase in helper/inducer T cells. Neither had any other underlying infections or autoimmune diseases. Thus it is possible that hypertrophic pachymeningitis developed as a result of multiorgan involvement of HTLV-I infection in these patients.
A 36 year old man noted tingling in his left cheek and left facial weakness followed by double vision and headache in July 1991. The neurological examination at admission disclosed left trigeminal, abducens and facial nerve paresis, and bilateral swollen discs. High dose oral corticosteroids alleviated the multiple cranial neuropathy. In July 1993 the tingling sensation of On brain MRI, diffuse thickening and gadolinium enhancement of the dura mater in the falx, cranial convexity, skull base, and cerebellar tentorium were evident (figure). An abnormal accumulation of gallium was seen in the parietal convexity by scintigraphy. High dose oral corticosteroids (60 mg/day) again alleviated both his symptoms and the gadolinium enhancement of the dura mater. PATENT 2 The patient was a 63 year old man. He presented with a three month history of bilateral Interestingly, cytokines, such as tumour necrosis factor-fl, secreted from the HTLV-Iinfected cell lines greatly enhance the proliferation of the fibroblasts."' Therefore, HTLV-I can contribute to the development of hypertrophic pachymeningitis, firstly through aberrant immune activation, and secondly through fibroblast growth promoting effects. It is notable that the considerable fibrous thickening of the meninges were commonly found in HAM/TSP."2 We therefore suggest that chronic hypertrophic pachymeningitis can occur as a part of multiorgan involvement in HTLV-I infection, and that the HTLV-I carrier state should be examined in this condition in HTLV-I endemic areas. Alternatively, in HTLV-I carriers, especially in those with inflammatory diseases who present with either headache or cranial neuropathy, a gadolinium enhanced MRI is warranted to look for pachymeningitis.
